CCS
USNA icon

Crosspoint Capital Strategies’s Usana Health Sciences USNA Stock Holding History

Crosspoint Capital Strategies’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,233
Closed -$1.48M – 57
2018
Q3 		$1.48M Sell
12,233
-362
-3% -$44.9K 2.41% 26
2018
Q2 		$1.45M Buy
+12,595
New +$1.38M 2.78% 18
2015
Q3 		– Sell
-152
Closed -$10K – 889
2015
Q2 		$10K Buy
+152
New +$9.65K ﹤0.01% 530

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crosspoint Capital Strategies's USNA Position: Q4 2018 in Review

Crosspoint Capital Strategies sold out of Usana Health Sciences (USNA) in Q4 2018, closing a stake of 12,233 shares — an estimated $1.48M sold.

Crosspoint Capital Strategies first reported a position in USNA in Q2 2015 and held it in 3 quarters. The position peaked at $1.48M in Q3 2018. 190 funds tracked by Wall St. Rank hold USNA as of Q4 2018.

  • Crosspoint Capital Strategies reported no remaining Usana Health Sciences position as of Q4 2018 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 12,233 Usana Health Sciences shares in Q4 2018, an estimated $1.48M.
  • Crosspoint Capital Strategies first reported a position in Usana Health Sciences in Q2 2015 and held it in 3 quarters.
  • Crosspoint Capital Strategies's Usana Health Sciences position peaked at $1.48M in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2018.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2018, filed 13 Feb 2019.